Sowell Financial Services’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-834
Closed -$29K 1120
2021
Q1
$29K Buy
834
+435
+109% +$24.8K ﹤0.01% 1883
2020
Q4
$28K Sell
399
-278
-41% -$11.4K ﹤0.01% 1600
2020
Q3
$19K Buy
677
+561
+484% +$18.3K ﹤0.01% 1575
2020
Q2
$3K Hold
116
﹤0.01% 2032
2020
Q1
$2K Buy
+116
New +$2.93K ﹤0.01% 2050

Other funds holding EDIT

Sowell Financial Services's EDIT Position: Q2 2021 in Review

Sowell Financial Services sold out of Editas Medicine (EDIT) in Q2 2021, closing a stake of 834 shares — an estimated $29K sold.

Sowell Financial Services first reported a position in EDIT in Q1 2020 and held it in 5 quarters. The position peaked at $29K in Q1 2021. 315 funds tracked by Wall St. Rank hold EDIT as of Q2 2021.

  • Sowell Financial Services reported no remaining Editas Medicine position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 834 Editas Medicine shares in Q2 2021, an estimated $29K.
  • Sowell Financial Services first reported a position in Editas Medicine in Q1 2020 and held it in 5 quarters.
  • Sowell Financial Services's Editas Medicine position peaked at $29K in Q1 2021.
  • 315 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.